| [1] | Dunn H.L. (1929) Application of statistical methods in physiology. Physiological Reviews 9:275–398.
|
| [2] | Greenwood M. (1932) What is wrong with the medical curriculum? Lancet 220:1269–1270. doi: 10.1016/S0140-6736(01)24285-8.
|
| [3] | Schor S, Karten I. (1966) Statistical evaluation of medical journal manuscripts. JAMA 195:1123–8. pmid:5952081 doi: 10.1001/jama.1966.03100130097026
|
| [4] | Altman DG. (1994) The scandal of poor medical research. BMJ 308:283–4. doi: 10.1136/bmj.308.6924.283. pmid:8124111
|
| [5] | Glasziou P, Meats E, Heneghan C, Shepperd S. (2008) What is missing from descriptions of treatment in trials and reviews? BMJ 336:1472–4. doi: 10.1136/bmj.39590.732037.47. pmid:18583680
|
| [6] | V？h？nikkil？ H1, Tj？derhane L, Nieminen P. (2014) The statistical reporting quality of articles published in 2010 in five dental journals. Acta Odontol Scand 6:1–5. doi: 10.3109/00016357.2014.954612
|
| [7] | Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, et al. (2008) Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 3:e3081. doi: 10.1371/journal.pone.0003081. pmid:18769481
|
| [8] | Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. (2012) Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med 156(5):340–9. doi: 10.7326/0003-4819-156-5-201203060-00005. pmid:22393129
|
| [9] | Mallett S, Timmer A, Sauerbrei W, Altman DG. (2010) Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines. Br J Cancer 102:173–180. doi: 10.1038/sj.bjc.6605462. pmid:19997101
|
| [10] | Papathanasiou AA, Zintzaras E. (2010) Assessing the quality of reporting of observational studies in cancer. Ann Epidemiol 20:67–73. doi: 10.1016/j.annepidem.2009.09.007. pmid:20006277
|
| [11] | Nature Special Series: Challenges in irreproducible research. Last Accessed: Nov 3, 2014.
|
| [12] | Editorial. Journals unite for reproducibility. Nature 2014;515:7 doi: 10.1038/515007a.
|
| [13] | Collins FS, Tabak LA. (2014) Policy: NIH plans to enhance reproducibility. Nature 505(7485):612–3 doi: 10.1038/505612a. pmid:24482835
|
| [14] | Chapman SJ, Shelton B, Mahmood H, Fitzgerald JE, Harrison EM, Bhangu A. Discontinuation and non-publication of surgical randomised controlled trials: observational study. BMJ 2014;349:g6870. doi: 10.1136/bmj.g6870. pmid:25491195
|
| [15] | Scherer RW, Langenberg P, von Elm E. (2007) Full publication of results initially presented in abstracts. Cochrane Database Syst Rev (2):MR000005 pmid:17443628 doi: 10.1002/14651858.mr000005.pub2
|
| [16] | Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, et al. (2014) Reducing waste from incomplete or unusable reports of biomedical research. Lancet 383:267–76. doi: 10.1016/S0140-6736(13)62228-X. pmid:24411647
|
| [17] | Simera I, Altman DG. (2009) Editorial: Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines. Ann Intern Med 151(4):JC2-2, JC2-3. doi: 10.7326/0003-4819-151-4-200908180-02002.
|
| [18] | Boutron I, Dutton S, Ravaud P, Altman DG. (2010) Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 303:2058–64. doi: 10.1001/jama.2010.651. pmid:20501928
|
| [19] | Kleinert S, Horton R. How should medical science change? Lancet 2014 Jan 18;383(9913):197–8. doi: 10.1016/S0140-6736(13)62678-1.
|
| [20] | Cobo E, Cortés J, Ribera JM, Cardellach F, Selva-O'Callaghan A, Kostov B, et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ. 2011 Nov 22;343:d6783. doi: 10.1136/bmj.d6783. pmid:22108262
|
| [21] | Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. Ann Intern Med. 2015;162(1):55–63 doi: 10.7326/M14-0697. pmid:25560714
|
| [22] | Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1. pmid:25554246
|
| [23] | Chan AW, Tetzlaff JM, G？tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: Guidance for protocols of clincial trials. BMJ 2013;346:e7586 doi: 10.1136/bmj.e7586. pmid:23303884
|
| [24] | Williamson P, Altman D, Blazeby J, Clarke M, Gargon E. (2012) Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy Jan;17(1):1–2. doi: 10.1258/jhsrp.2011.011131. pmid:22294719
|
| [25] | Tenaerts P, Madre L, Archdeacon P, Califf RM. The Clinical Trials Transformation Initiative: innovation through collaboration. Nat Rev Drug Discov 2014 Nov;13(11):797–8. doi: 10.1038/nrd4442. pmid:25359366
|
| [26] | Moher D. (2014) Along with the privilege of authorship come important responsibilities. BMC Med 12(1):214. doi: 10.1186/s12916-014-0214-2. pmid:25344218
|
| [27] | Jefferson T, Rudin M, Brodney Folse S, Davidoff F. (2007) Editorial peer review for improving the quality of reports of biomedical studies. Cochrane Database Syst Rev (2):MR000016. doi: 10.1002/14651858.MR000016.pub3. pmid:17443635
|
| [28] | Hopewell S, Collins GS, Boutron I, Yu LM, Cook J, et al. (2014) Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study. BMJ 349:g4145 doi: 10.1136/bmj.g4145. pmid:24986891
|
| [29] | Smith R. Medical journals: “a colossal problem of quality” Last Accessed Nov 3 2014.
|
| [30] | Hirst A, Altman DG. (2012) Are Peer Reviewers Encouraged to Use Reporting Guidelines? A Survey of 116 Health Research Journals. PLoS ONE 7(4): e35621. 10.1371 doi: 10.1371/journal.pone.0035621. pmid:22558178
|
| [31] | Patel J. (2014) Why training and specialization is needed for peer review: a case study of peer review for randomized controlled trials. BMC Medicine 12:128. doi: 10.1186/s12916-014-0128-z. pmid:25285376
|
| [32] | Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, et al. (2014) Biomedical research: increasing value, reducing waste. Lancet 383(9912):101–4. doi: 10.1016/S0140-6736(13)62329-6. pmid:24411643
|
| [33] | World Medical Association. WMA Declaration of Helsinki—Ethical principles for medical research involving human subjects. Last accessed: Nov 3, 2014.
|
| [34] | National Institutes of Health. Proposed Principles and Guidelines for Reporting Preclinical Research. Last Accessed: Nov 24, 2014.
|
